Brean Murray Downgrades China Medical (CMED) to Hold; Valuation Call

April 27, 2009 8:45 AM EDT

Brean Murray downgrades China Medical (Nasdaq: CMED) from Buy to Hold.

Brean analyst says, "CMED has exceeded our price target of $20. The stock has performed well and has returned ~80% over the last 2 months. Our proprietary leading indicator now suggests a neutral stance. We are hence lowering our recommendation to Hold."

China Medical Technologies, Inc. is a China-based medical device company that develops, manufactures and markets in-vitro diagnostics (IVD) products using chemiluminescence immunoassay technology, magnetic antibody immunoassay technology and fluorescent in situ hybridization technology.

To see more analyst ratings on CMED Click Here
 


Related Categories

Downgrades

Stocks Mentioned

CMED 15.02

+0.00 +0.00%
Volume: 339,514
Track CMED


Related Entities



Comments

Downgrading of CMED
Glenn on Jun 2, 2009 02:45 PM

So.... I guess you can see what I was referring to on April 28th.

Downgrading of CMED
Glenn on Apr 28, 2009 04:17 AM

Wow! Good for the bean heads at Brean Murray! Fortunately, the great majority of investors know enough to look past their silly ratings. Watch this stock make some major ground in the next 6 months.


Add Your Comment